Key facts
- It has raised $112.3M; the latest was Early Stage VC ($112.3M) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Hualan Gene
- ·The full record, as it builds
Funding rounds
No funding rounds for Hualan Gene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hualan Gene
Producer of a traditional herbal medicine and edibles intended to modernize and globalize the use of therapeutic botanicals. The company offers integrated capabilities in cultivation, processing, and product development of medicinal plants, enabling health-focused consumers, wellness brands, and clinical institutions to have consistent access to standardized and culturally rooted healthcare products.
- Sector
- Healthcare
- HQ
- Guilin, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Hualan Gene doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hualan Gene shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hualan Gene in its N-PORT filings yet. We sweep new filings monthly.